Skip to main content
. 2016 May 31;7(28):44330–44339. doi: 10.18632/oncotarget.9736

Table 2. Genotypes of 11 SNPs of FBW7 and its substrate genes and their association with efficacy of paclitaxel.

Gene (Genotypes) PD+SD(%) PR(%) χ2 OR(95%CI)a Pa
rs210940(myb)
 CC 22(36.7) 14(26.4) reference
 CT 32(53.3) 29(54.7) 2.42 2.70(0.70,10.35) 0.15
 TT 6(10.0) 10(18.9) 0.68 1.07(0.42,2.74) 0.88
rs7435589(myb)
 AA 27(45.0) 22(42.3) reference
 AG 28(46.7) 24(46.2) 0.02 0.89(0.37,2.12) 0.79
 GG 5(8.3) 6(11.5) 0.33 1.36(0.33,5.62) 0.67
rs1057079(mTOR)
 AA 47(77.0) 27(50.9) reference
 AG 14(23.0) 25(47.2) 7.58 4.59(1.78,11.86) <0.01
 GG 0(0.0) 1 (1.9) 0.00 1.00
rs17036508(mTOR)
 TT 54(90.0) 45(86.5) reference
 TC 6(10.0) 7(13.5) 0.32 0.89(0.24,3.27) 0.86
rs2536(mTOR)
 TT 53(86.9) 46(83.6) reference
 TC 7(11.5) 9(16.4) 0.52 1.47(0.46,4.74) 0.52
 CC 1(1.6) 0(0.0) 0.00 1.00
rs2295080(mTOR)
 TT 40(76.9) 28(59.6) reference
 TG 9(17.3) 16(34.0) 3.71 2.52(0.88,7.23) 0.08
 GG 3(5.8) 3(6.4) 0.18 1.48(0.23,9.73) 0.68
rs3124591(NOTCH1)
 TT 48(78.7) 43(81.1) reference
 TC 7(11.5) 7(13.2) 0.62 0.73(0.16,3.26) 0.68
 CC 6(9.8) 3(5.7) 0.04 1.07(0.31,3.72) 0.92
rs10521(NOTCH1)
 AA 49(80.3) 43(78.2) reference
 AG 10(16.4) 11(20.0) 0.20 2.25(0.18,27.78) 0.52
 GG 2(3.3) 1(1.8) 0.37 4.41(0.29,66.09) 0.28
rs9642880(c-Myc)
 GG 26(42.6) 30(56.6) reference
 GT 9(14.8) 8(15.1) 0.22 0.99(0.30,3.24) 0.99
 TT 26(42.6) 15(28.3) 2.72 0.48(0.19,1.23) 0.12
rs9902941(SREBF2)
 CC 54(88.5) 49(92.5) reference
 CT 6(9.8) 4(7.5) 0.21 0.88(0.18,4.29) 0.88
 TT 1(1.6) 0(0.0) 0.00 1.00
rs7685296(FBW7)
 CC 23(37.1) 21(41.2) reference
 CT 6(9.7) 8(15.7) 0.38 1.06(0.28,4.06) 0.93
 TT 33(53.2) 22(43.1) 0.59 0.89(0.36,2.22) 0.80
a

Adjusted for sex, age, and chemotherapy cycle